Abstract
Mutagenesis and carcinogenesis are complex cellular processes which are grossly similar in that each produces heritable changes in phenotype. Experimental mutagenesis by a pure chemical agent was first achieved by Auerbach and Robson (1944, 1946) and a variety of such agents are now known. Their mechanisms of action appear to be fairly well understood as consisting of expressible heritable changes in the molecular structure of the genetic material or DNA (Orgel, 1965; Freese and Freese, 1966; Auerbach, 1967; Freese, this book). Carcinogenesis by chemical agents was discovered first in humans almost 200 years ago, and today nearly a dozen agents active in the human and of widely varying structure are known (Clayson, 1962; Hueper and Conway, 1964; Miller, J. A., 1970). The experimental induction of cancer with a pure chemical compound was first achieved about 1930, and many chemical carcinogens of greatly differing structures are known today (see preceding references). However, it is not known at the molecular level how any chemical carcinogen induces the formation of cells which are not responsive to the growth controls of the host and which form neoplasms that grow more or less continuously and may invade normal tissues. This is also true of the carcinogenic action of viruses and radiation. Likewise, the molecular phenotype of no neoplasm is even partially understood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abell, C. W., Falk, H. L., Shimkin, M. B., Weisburger, E. K., Weisburger, J. H., and Gubareff, N. (1965), Science 147, 1443.
Alderson, T., and Clark, A. M. (1966), Nature 210, 593.
Andersen, R. A., Enomoto, M., Miller, E. C., and Miller, J. A. (1964), Cancer Res. 24, 128.
Auerbach, C. (1939–40), Proc. Roy. Soc. Edinburgh, Ser. B. 60, 164 (quoted by Burdette, W. J. (1955), Cancer Res. 15, 201).
Auerbach, C. (1967), Science 158, 1141.
Auerbach, C., and Robson, J. M. (1944), Nature 154, 81.
Auerbach, C., and Robson, J. M. (1946), Nature 157, 302.
Bauer, K. H. (1928), “Mutationstheorie der Geschwulst-Enstehung. Übergang von Körperzellen in Geschwulstzellen durch Gen-Änderung, ” Springer-Verlag, Berlin.
Bauer, K. H. (1963) “Das Krebsproblem, ” Springer-Verlag, Berlin.
Baldwin, R. W., and Smith, W. R. D. (1965), Brit. J. Cancer 19, 433.
Barratt, R. W., and Tatum, E. L. (1951), Cancer Res. 11, 234.
Barratt, R. W., and Tatum, E. L. (1958), Ann. N.Y. Acad. Sci. 71, 1072.
Bateman, A. J. (1967), Mutation Res. 4, 710.
Belman, S., Troll, W., Teebor, G., and Mukai, F. (1968), Cancer Res. 28, 535.
Bhattacharya, S. A. (1949), Proc. Zool. Soc. Bengal 2, 187 (quoted by Burdette, W. J. (1955), Cancer Res. 15, 201).
Boutwell, R. K., Colburn, N. H., and Muckerman, C. C. (1969), Ann. N.Y. Acad. Sci. 163, 751.
Boveri, T. (1929), “The Origin of Malignant Tumors” (first published Jena, 1914), Williams and Wilkins Co., Baltimore.
Boyland, E. (1964), Brit. Med. Bull. 20, 121.
Boyland, E. (1969), in “The Jerusalem Symposia on Quantum Chemistry and Biochemistry. Vol. I. Physico-Chemical Mechanisms of Carcinogenesis” (E. D. Bergmann and B. Pullman, eds.) p. 25, Israel Academy of Sciences and Humanities, Jerusalem.
Boyland, E., and Nery, R. (1965), Biochem. J. 94, 198.
Boyland, E., and Sims, P. (1962), Biochem. J. 84, 571.
Boyland, E., and Sims, P. (1964), Biochem. J. 91, 493.
Boyland, E., and Sims, P. (1965a), Biochem. J. 95, 780.
Boyland, E., and Sims, P. (1965b), Biochem. J. 95, 788.
Boyland, E., and Sims, P. (1965c), Biochem. J. 97, 7.
Boyland, E., and Sims, P. (1967), Internat. J. Cancer 2, 500.
Boyland, E., and Williams, K. (1969), Biochem. J. 111, 121.
Boyland, E., Dukes, C. E., and Grover, P. L. (1963), Brit. J. Cancer 18, 575.
Boyland, E., Busby, E. R., Dukes, C. E., Grover, P. L., and Manson, D. (1964), Brit. J. Cancer 19, 575.
Boyland, E., Sims, P., and Huggins, C. (1965), Nature 207, 816.
Brink, N. G. (1966), Mutation Res. 3, 66.
Brink, N. G. (1969), Mutation Res. 8, 139.
Brookes, P., and Dipple, A. (1967), “British Empire Cancer Campaign 45th Annual Report, ” Part II, p. 20.
Brookes, P., and Dipple, A. (1969), in “The Jerusalem Symposia on Quantum Chemistry and Biochemistry. Vol. I. Physico-Chemical Mechansisms of Carcinogenesis” (E. D. Bergmann and B. Pullman, eds.) p. 139, Israel Academy of Sciences and Humanities, Jerusalem.
Brookes, P., and Lawley, P. D. (1960), Biochem. J. 77, 478.
Brookes, P., and Lawley, P. D. (1964), J. Cell. Comp. Physiol. 64 (Suppl. 1), 111.
Brown, G. B., Sugiura, K., and Cresswell, R. M. (1965), Cancer Res. 25, 986.
Bryan, G. T., Brown, R. R., and Price, J. M. (1964), Cancer Res. 24, 596.
Büch, H., Rummel, W., Pfleger, K., Eschrich, C., and Texter, N. (1968), Naunyn-Schmiedebergs Arch. Pharm. Exp. Pathol. 259, 276.
Bull, L. B., Culvenor, C. C. J., and Dick, A. T. (1968), “The Pyrrolizidine Alkaloids, ” North Holland Publishing Co., Amsterdam.
Burdette, W. J. (1952), Cancer Res. 12, 201.
Burdette, W. J. (1955), Cancer Res. 15, 201.
Burdette, W. J., and Haddox, C. H., Jr. (1954), Cancer Res. 14, 163.
Butler, T. C. (1961), J. Pharmacol. Exp. Therap. 134, 311.
Cessi, C., Colombini, C., and Mameli, L. (1966), Biochem. J. 101, 46c.
Chu, E. H. Y., Bailiff, E. E., and Mailing, H. V. (1970), “Abstracts Tenth International Cancer Congress, ” p. 62, Houston.
Clark, A. M. (1960), Z. Vererb. 91, 74.
Clark, A. M. (1963), Z. Vererb. 94, 115.
Clayson, D. B. (1962), “Chemical Carcinogenesis, ” Little, Brown Co., Boston.
Cleaver, J. E. (1969), Radiation Res. 37, 334.
Colburn, N. H., and Boutwell, R. K. (1968a), Cancer Res. 28, 642.
Colburn, N. H., and Boutwell, R. K. (1968b), Cancer Res. 28, 653.
Corbett, T. H., Dove, W. F., and Heidelberger, C. (1970), Mol. Pharmacol., in press.
Costa, A., Weber, G., and St. Omer, F. B. (1963), Arch. de Vecchi Anat. Path. 39, 357.
Cramer, J. W., Miller, J. A., and Miller, E. C. (1960), J. Biol. Chem. 235, 250.
Culvenor, C. C. J., Dann, A. T., and Dick, A. T. (1962), Nature 195, 570.
Culvenor, C. C. J., Downing, D. T., Edgard, J. A., and Jago, M. V. (1969), Ann. Ann. N.Y. Acad. Sci. 163, 837.
DeBaun, J. R., Miller, E. C., and Miller, J. A. (1970a), Cancer Res., 30, 577.
DeBaun, J. R., Smith, J. Y. R., Miller, E. C., and Miller, J. A. (1970b), Science 167, 184.
Della Porta, G., Terracini, B., and Shubik, P. (1961), J. Nat. Cancer Inst. 26, 855.
Demerec, M. (1948), “Proceedings of the Eighth International Congress on Genetics, ” p. 201, Hereditas Supplement.
Demerec, M., and Hanson, J. (1951), Cold Spring Harbor Symp. Quant. Biol. 16, 215.
Demerec, M., Wallace, B., Witkin, E. M., and Bertani, G. (1949), Carnegie Inst. Wash. Year Book 48, 156.
Demerec, M., Bertani, G., and Flint, J. (1951), Am. Nat. 85, 119.
Dipple, A., and Slade, T. A. Europ. J. Cancer (in press).
Druckrey, H., Steinhoff, D., Beuthner, H., Schneider, H., and Klämer, P. (1963), Arzneimittel-Forsch. 13, 320.
Druckrey, H., Preussmann, R., Ivankovic, S., Schmähl, D., Afkham, Blum, G., Mennel, H. D., Muller, M., Petropoulos, P., and Schneider, H. (1967), Z. Krebsforsch. 69, 103.
Druckrey, H., Kruse, H., and Preussmann, R. (1968), Naturwissenschaften 55, 449.
Druckrey, H., Preussmann, R., and Ivankovic, S. (1969), Ann. N.Y. Acad. Sci. 163, 676.
Endo, H. (1958), Gann, 49, 151.
Endo, H., and Kume, F. (1965), Gann 56, 261.
Endo, H., Wada, A., Miura, K. I., Hidaka, Z., and Hiruki, C. (1961), Nature 190, 833.
Enomoto, M., Sato, K., Miller, E. C., and Miller, J. A. (1968), Life Sci. 7, 1025.
Epstein, S. S. (1970), in “Environmental Chemical Mutagens—Principles and Methods for Their Detection” (A. Hollander, ed.) Plenum Press, New York.
Epstein, S. S., and St. Pierre, J. A. (1969), Toxicol. Appl. Pharmacol. 15, 451.
Epstein, S. S., and Shafner, H. (1968) Nature 219, 385.
Fahmy, O. G., and Fahmy, M. J. (1969), Nature 224, 1328.
Fahmy, O. G., and Fahmy, M. J. (1970), Cancer Res. 30, 195.
Farber, E. (1963), Adv. Cancer Res. 7, 383.
Farber, E., McConomy, J., Franzen, B., Marroquin, F., Stewart, G. A.., and Magee., P. N. (1967), Cancer Res. 27, 1761.
Fowler, J. S. L. (1969), Brit. J. Pharmacol. 36, 181P.
Freese, E. (1963), in “Molecular Genetics” (J. H. Taylor, ed.) Part I, Chapter V, Academic Press, New York.
Freese, E. (1970), in “Environmental Chemical Mutagens—Principles and Methods for Their Detection” (A. Hollander, ed.) Plenum Press, New York.
Freese, E., and Freese, E. B. (1966), Radiation Res. 6 (Suppl.), 97.
Freese, E., and Strack, H. B. (1962). Proc. Nat. Acad. Sci., 48, 1796.
Freese, E., Bautz, F., and Freese, E. B. (1961), Proc. Nat. Acad. Sci. 47, 845.
Fried, J., and Schumm, D. E. (1967), J. Am. Chem. Soc. 89, 5508.
Gabridge, M. G., and Legator, M. S. (1969), Proc. Soc. Exp. Biol. Med. 130, 831.
Gelboin, H. V. (1967), Adv. Cancer Res. 10, 1.
Gelboin, H. V. (1969), Cancer Res. 29, 1272.
Giovanni-Donnelly, R. de, Kolbye, S. M., and DiPaolo, J. A. (1967), Mutation Res. 4, 543.
Goldschmidt, B. M., Blazej, T. P., and Van Duuren, B. L. (1968), Tetrahedron Letters, p. 1583.
Goodall, C. M., and Butler, W. H. (1969), Internat. J. Cancer 4, 422.
Grasso, P., and Golberg, L. (1966), Food Cosmet. Toxicol. 4, 297.
Grover, P. L., and Sims, P. (1969), Biochem. J. 110, 159.
Grover, P. L., and Sims, P. (1970), Biochem. Pharmacol. 19, 2251.
Haddow, A., and Horning, E. S. (1960), J. Nat. Cancer Inst. 24, 109.
Hartwell, J. L. (1951), “Survey of Compounds Which Have Been Tested for Carcinogenic Activity, ” U.S. Public Health Service Publication No. 149.
Heidelberger, C. (1964), J. Cell. Comp. Physiol. 64 (Suppl. 1), 129.
Hueper, W. C., and Conway, W. D. (1964), “Chemical Carcinogenesis and Cancers, ” Charles C Thomas, Springfield, Ill.
Iijima, T., and Hagiwara, A. (1960), Nature 185, 395.
Ikegami, R., Akamatsu, Y., and Haruta, M (1967), Acta Pathol. Japan 17, 495.
Innes, J. R. M., Ulland, B. M., Valerno, M. G., Petrucelli, L., Fishbein, L., Hart, E. R., Pallotta, A. J., Bates, R. R., Falk, H. L., Gart, J. J., Klein, M., Mitchell, I., and Peters, J. (1969), J. Nat. Cancer Inst. 42, 1101.
Irving, C. C. (1962), Cancer Res. 22, 867.
Irving, C. C. (1965), J. Biol. Chem. 240, 1011.
Irving, C. C., and Russell, L. T. (1970), Biochemistry 9, 2471.
Irving, C. C., and Veazey, R. A. (1969), Cancer Res. 29, 1799.
Irving, C. C., Gutmann, H. R., and Larson, D. M. (1963), Cancer Res. 23, 1782.
Irving, C. C., Wiseman, R., Jr., and Hill, J. T. (1967), Cancer Res. 27, 2309.
Irving, C. C., Veazey, R. A., and Hill, J. T. (1969a), Blochim. Biophys. Acta 179, 189.
Irving, C. C., Veaszey, R. A., and Russell, L. T. (1969b), Chemico-Biol. Interactions 1, 19.
Jensen, K. A., Kirk, I., Kolmark, G., and Westergaard, M. (1951), Cold Spring Harbor Symp. Quant. Biol. 16, 245.
Juhasz, J. (1967), in “Potential Carcinogenic Hazards from Drugs” (R. Truhaut, ed.), U.I.C.C. Monograph, Vol. 7, p. 180 Springer-Verlag, Berlin.
Kimball, R. F. (1968), Photochem. Photobiol. 8, 515.
Koller, P. C. (1969), Mutation Res. 8, 199.
Krieg, D. R. (1963), Prog. Nucleic Acid Res. 2, 125.
Kriek, E. (1968), Biochim. Biophys. Acta 161, 273.
Kriek, E. (1969), Chemico-Biol. Interactions 1, 3.
Kriek, E., Miller, J. A., Juhl, U., and Miller, E. C. (1967), Biochemistry 6, 117.
Krüger, F. W., Preussmann, R., and Niepelt, N. (1970), “Abstracts, Tenth International Cancer Congress, ” p. 4, Houston.
Laqueur, G. L., and Matsumoto, H. (1966), J. Nat. Cancer Inst. 37, 217.
Laqueur, G. L., and Spatz, M. (1968), Cancer Res. 28, 2262.
Laqueur, G. L., McDaniel, E. G., and Matsumoto, H. (1967), J. Nat. Cancer Inst. 39, 355.
Latarjet, R., Buu-Hoi, N. P., and Elias, C. A. (1950), Publ. Staz. Zool. Napoli 22, 78 (quoted by Burdette, W. J. (1955), Cancer Res. 15, 201).
Lawley, P. D. (1966), Prog. Nucleic Acid Res. 5, 89.
Lawley, P. D., and Brookes, P. (1963), Biochem. J. 89, 127.
Lawley, P. D., and Thatcher, C. J. (1970), Biochem. J. 116, 693.
Lee, K. Y., and Goodall, C. M. (1968), Biochem. J. 106, 767.
Legator, M., and Epstein, S. S. (in press), in “Non-psychiatric Hazards of Drugs of Abuse” (S. S. Epstein and J. Lederberg, eds.) National Institutes of Mental Health, U.S. Government Printing Office.
Legator, M. S., and Mailing, H. V. (1971), in “Chemical Mutagens—Principles and Methods for Their Detection (A. Hollaender, ed.) Plenum Press, New York.
Lerman, L. S. (1965), J. Cell. Comp. Physiol. 64 (Suppl. 1), 1.
Lijinsky, W., and Ross, A. E. (1969), J. Nat. Cancer Inst. 42, 1095.
Lin, J.-K., Miller, J. A., and Miller, E. C. (1968), Biochemistry 7, 1889.
Lin, J.-K., Miller, J. A., and Miller, E. C. (1969), Biochemistry 8, 1573.
Lotlikar, P. D., Scribner, J. D., Miller, J. A., and Miller, E. C. (1966), Life Sci. 5, 1263.
Loveless, A. (1969), Nature 223, 206.
Magee, P. N., and Barnes, J. M. (1967), Adv. Cancer Res. 10, 163.
Magee, P. N., and Schoental, R. (1964), Brit. Med. Bull. 20, 102.
Maher, V. M., and Summers, W. C. (1970), Nature 225, 68.
Maher, V. M., Miller, E. C., Miller, J. A., and Szybalski, W. (1968), Mol. Pharmacol. 4, 411.
Maher, V. M., Miller, E. C., Miller, J. A., and Summers, W. C. (1970), Cancer Res., 30, 1473.
Maisin, J. H., Lambert, G., and Van Duyse, E. (1953), Acta Unio Internat. Contra Cancrum 9, 693.
Malling, H. V. (1966), Mutation Res. 3, 537.
Malling, H. V., and Cosgrove, G. E., “Proc. Symposium: Chemische Mutagenese bei Sauger und Mensch. Test Systeme und Ergebnisse, ” Mainz, Germany (October 5–8, 1969) (in press).
Malling, H. V., and de Serres, F. J. (1969), Ann. N.Y. Acad. Sci. 163, 788.
Matsumoto, H., and Higa, H. H. (1966), Biochem. J. 98, 20C.
Matsushima, T., Kobuna, I., and Sugimura, T. (1967), Nature 216, 508.
Matsushima, T., Kobuna, I., Fukuoka, F., and Sugimura, T. (1968), Gann 59, 247.
Mattocks, A. R. (1968), Nature 217, 723.
Miller, E. C., and Miller, J. A. (1966), Pharmacol. Rev. 18, 805.
Miller, E. C., and Miller, J. A. (1967), Proc. Soc. Exp. Biol. Med. 124, 915.
Miller, E. C., Sandin, R. B., Miller, J. A., and Rusch, H. P. (1956), Cancer Res. 16, 525.
Miller, E. C., Miller, J. A., and Hartmann, H. A. (1961), Cancer Res. 21, 815.
Miller, E. C., Miller, J. A., and Enomoto, M. (1964), Cancer Res. 24, 2018.
Miller, E. C., Juhl, U., and Miller, J. A. (1966a), Science 153, 1125.
Miller, E. C., Lotlikar, P. D., Pitot, H. C., Fletcher, T. L., and Miller, J. A. (1966b), Cancer Res. 26, 2239.
Miller, E. C., Lotlikar, P. D., Miller, J. A. Butler, B. W., Irving, C. C., and Hill, J. T. (1968), Mol. Pharmacol. 4, 147.
Miller, E. C., Smith, J. Y., and Miller, J. A. (1970), Proc. Am. Assoc. Cancer Res. 11, 56.
Miller, J. A. (1970), Cancer Res., 30, 559.
Miller, J. A., and Miller, E. C. (1953), Adv. Cancer Res. 1, 339.
Miller, J. A., and Miller, E. C. (1969a), Prog. Exp. Tumor Res. 11, 273.
Miller, J. A., and Miller, E. C. (1969b), in “The Jerusalem Symposia on Quantum Chemistry and Biochemistry. Vol. I. Physico-Chemical Mechanisms of Carcinogenesis” (E. D. Bergman and B. Pullman, eds.) p. 237, The Israel Academy of Sciences and Humanities, Jerusalem.
Miller, J. A., Sandin, R. B., Miller, E. C., and Rusch, H. P. (1955), Cancer Res. 15, 188.
Miller, J. A., Wyatt, C. S., Miller, E. C., and Hartmann, H. A. (1961), Cancer Res. 21, 1465.
Miller, J. A., Lin, J.-K., and Miller, E. C. (1970), Proc. Am. Assoc. Cancer Res. 11, 56.
Mirvish, S. S. (1968), Adv. Cancer Res. 11, 1.
Morreal, C. E., Dao, T. L., Eskins, K., King, C. L., and Dienstag, J. (1969), Biochim. Biophys. Acta 169, 224.
Mukai, F., and Troll, W. (1969), Ann. N.Y. Acad. Sci. 163, 828.
Munn, A. (1967), in “Bladder Cancer, A Symposium” (W. B. Deichmann, K. F. Lampe, R. A. Penalver, A. Soto, and J. L. Radomski, eds.) p. 187, Aesculapius Publishing Co., Birmingham, Ala.
Nagai, S. (1969), Mutation Res. 7, 333.
Nagata, Y., and Matsumoto, H. (1969), Proc. Soc. Exp. Biol. Med. 132, 383.
Nakahara, W., Fukuoka, F., and Sugimura, T. (1957), Gann 48, 129.
Nery, R. (1969), J. Chem. Soc., p. 1860.
Orenstein, J. M., and Marsh, W. H. (1968), Biochem. J. 109, 697.
Orgel, L. E. (1965), Adv. Enzymol. 27, 289.
Ortwerth, B. J., and Novelli, G. D. (1969), Cancer Res. 29, 380.
Perez, G., and Radomski, J. L. (1965), Ind. Med. Surg. 34, 714.
Pitot, H. C., and Heidelberger, C. (1963), Cancer Res. 23, 1694.
Poirier, L. A. (1965), Ph.D. thesis, University of Wisconsim, Madison, Wis.
Poirier, L. A., Miller, J. A., Miller, E. C., and Sato, K. (1967), Cancer Res. 27, 1600.
Preussman, R., Druckrey, H., and Bücheler, J. (1968), Z. Krebsforsch. 71, 63.
Preussman, R., Druckrey, H., Ivankovic, S., and Von Hodenberg, A. (1969a), Ann. N.Y. Acad. Sci. 163, 697.
Preussman, R., Von Hodenberg, A., and Hengy, H. (1969b), Biochem. Pharmacol. 18, 1.
Price, C. C., Gaucher, G. M., Koneru, P., Shibakawa, R., Sowa, J. R., and Yamaguchi, M. (1968), Biochim. Biophys. Acta 166, 327.
Rao, K. S., and Recknagel, R. O. (1969), Exp. Mol. Pathol. 10, 219.
Reuber, M. D., and Glover, E. L. (1970), J. Nat. Cancer Inst. 44, 419.
Reynolds, E. S. (1967), J. Pharmacol. Exp. Therap. 155, 117.
Roe, F. J. C. (1957), Cancer Res. 17, 64.
Rosen, L. (1968), Biochem. Biophys. Res. Commun. 33, 546.
Ross, W. C. J. (1962), “Biological Alkylating Agents, ” Butterworth and Co., London.
Sacharov, V. V. (1938), Biol. Zh. 7, 595 (quoted by Burdette, W. J. (1955), Cancer Res. 15, 201).
Salaman, M. H., and Roe, F. J. C. (1956), Brit. J. Cancer 10, 363.
Scherr, G. H., Fishman, M., and Weaver, R. H. (1954), Genetics 39, 141.
Schoental, R. (1963), Bull. World Health Org. 29, 823.
Schoental, R. (1968a), Cancer Res. 28, 2237.
Schoental, R. (1968b), Israel J. Med. Sci. 4, 1133. Scribner, J. D., Miller, E. C., and Miller, J. A., Unpublished data.
Scribner, J. D., Miller, J. A., and Miller, E. C. (1965), Biochem. Biophys. Res. Commun. 20, 560.
Scribner, J. D., Miller, J. A., and Miller, E. C. (1970), Cancer Res., 30, 1570.
Shapiro, R. (1968), Prog. Nucleic Acid Res. Mol. Biol. 8, 73.
Shapiro, R. (1969), Ann. N.Y. Acad. Sci. 163, 624.
Shirasu, Y. (1965), Proc. Soc. Exp. Biol. Med. 118, 812.
Singer, B., and Fraenkel-Conrat, H. (1969), Prog. Nucleic Acid Res. Mol. Biol. 9, 1.
Smith, D. W. E. (1966), Science 152, 1273.
Smith, R. H. (1969), Mutation Res. 7, 231.
Spatz, M. (1968), Proc. Soc. Exp. Biol. Med. 128, 1005.
Spatz, M. (1969), Ann. N.Y. Acad. Sci. 163, 848.
Stekol, J. A. (1963), Adv. Enzymol. 25, 369.
Stekol, J. A. (1965), in “Transmethylation and Methionine Biosynthesis” (S. K. Shapiro and F. Schlenk, eds.) p. 231, University of Chicago Press, Chicago. Stöhrer, G., and Brown, G. B. (1970), Science 167, 1622.
Stöhrer, G., Corbin, E., and Brown, G. B. (1970), Proc. Am. Assoc. Cancer Res. 11, 76.
Strong, L. C. (1945), Proc. Nat. Acad. Sci. 31, 290.
Strong, L. C. (1952), Cancer Res. 12, 300.
Sugimura, T., Okabe, K., and Endo, H. (1965), Gann 56, 489.
Sugiura, K., Teller, M. N., Parham, J. C., and Brown, G. B. (1970), Cancer Res. 30, 184.
Swann, P. F., and Magee, P. N. (1968), Biochem. J. 110, 39.
Swann, P. F., and Magee, P. N. (1969), Nature 223, 947.
Szybalski, W., and Iyer, V. N. (1967), in “Antibiotics” (D. Gottlieb and P. D. Shaw, eds.) Vol. I, p. 211, Springer-Verlag, Berlin.
Szybalski, W., Bovre, K., Fiandt, M., Guha, A., Hradecna, Z., Kumar, S., Lozeron, H. A., Maher, V. M., Nijkamp, H. J. J., Summers, W. C., and Taylor, K. (1969), J. Cell. Physiol 74 (Suppl. 1), 33.
Tada, M., Tada, M., and Takahashi, T. (1967), Biochem. Biophys. Res. Commun. 29, 469.
Trainin, N., Kaye, A. M., and Berenblum, I. (1964), Biochem. Pharmacol. 13, 263.
Ts’o, P. O. P., Lesko, S. A., and Umans, R. S. (1969), in “The Jerusalem Symposia on Quantum Chemistry and Biochemistry. Vol. I. Physico-Chemical Mechanisms of Carcinogenesis” (E. D. Bergman and B. Pullman, eds.) p. 106, Israel Academy of Sciences and Humanities, Jerusalem.
Udenfriend, S., Clark, C. T., Axelrod, J., and Brodie, B. B. (1954), J. Biol. Chem. 208, 731.
Van Duuren (1969), Ann. N.Y. Acad. Sci. 163, 633.
Van Duuren, B. L., and Sivak, A. (1968), Cancer Res. 28, 2349.
Van Duuren, B. L., Langseth, L., Goldschmidt, B. M., and Orris, L. (1967), J. Nat. Cancer Inst. 39, 1217.
Van Duuren, B. L., Sivak, A., Katz, C., and Melchionne, S. (1969), Brit. J. Cancer 23, 587.
Vogt, M. (1948), Experientia 4, 68.
Weinstein, I. B. (1969), in “Genetic Concepts and Neoplasia, Twenty-third Annual Symposium on Fundamental Cancer Research, ” p. 380, Williams and Wilkins, Baltimore.
Weisburger, E. K., and Weisburger, J. H. (1958), Adv. Cancer Res. 5, 331.
Weisburger, J. H., Yamamoto, R. S., Grantham, P. H., and Weisburger, E. K. (1970), Proc. Am. Assoc. Cancer Res. 11, 82.
Wilk, M., and Girke (1969), in “The Jerusalem Symposia on Quantum Chemistry and Biochemistry. Vol. I. Physico-Chemical Mechanisms of Carcinogenesis” (E. D. Bergmann and B. Pullman, eds.) p. 91, Israel Academy of Sciences and Humanities, Israel.
Wilk, M., and Hoppe, U. (1970), Liebigs Ann. Chem. 727, 81.
Wogan, G. N. (1966), Bacteriol. Rev. 30, 460.
Wölcke, U., Birdsall, N. J. M., and Brown, G. B. (1969), Tetrahedron Letters 10, 785.
Wolff, S., and Scott, D. (1969), Exp. Cell Res. 55, 9.
Yamamoto, R. S., Glass, R. M., Fankel, H. H., Weisburger, E. K., and Weisburger, J. H. (1968), Toxicol. Appl. Pharmacol. 13, 108.
Zimmerman, F. K. (1969a), Z. Krebsforsch. 72, 65.
Zimmerman, F. K. (1969b), Arzneimittel-Forsch. 7, 1046.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Plenum Press, New York
About this chapter
Cite this chapter
Miller, E.C., Miller, J.A. (1971). The Mutagenicity of Chemical Carcinogens: Correlations, Problems, and Interpretations. In: Hollaender, A. (eds) Chemical Mutagens. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8966-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-8966-2_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-8968-6
Online ISBN: 978-1-4615-8966-2
eBook Packages: Springer Book Archive